The clinical and biological response to allergen-specific immunotherapy with basophil activation test (BAT) in the atopic diseases Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015
Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure Source: Eur Respir J 2004; 24 : 750-757 Year: 2004
Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Basophil activation test as support for distinguishing between aspirin-induced asthma and allergic reaction to ASA Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response Source: Eur Respir J 2003; 22: 118-126 Year: 2003
Inhalation of mannitol, used as a model for exercise-induced bronchoconstriction (EIB), causes release of leukotrienes and a mast cell marker in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 102s Year: 2001
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Source: Eur Respir J 2001; 18: 254-261 Year: 2001
Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006
Cellular and biochemical changes induced by specific inhalation challenge test in bakers with allergic rhinitis and with bronchial asthma accompanied by rhinitis Source: Eur Respir J 2004; 24: Suppl. 48, 369s Year: 2004
The effects of two weeks of repeated low-dose allergen exposure on sputum eosinophilic and neutrophilic inflammation in atopic asthma: protection by inhaled steroids? Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Reduced late asthmatic response by repeated low-dose allergen exposure Source: Eur Respir J 2001; 17: 872-880 Year: 2001
One-year sublingual immunotherapy in asthmatic children do not influence on basophil’s CD203c stimulated and spontaneous expression Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
LSC Abstract – Changes of peripheral blood eosinophil activity during allergen-induced late-phase airway inflammation in asthma Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
The role of T-lymphocytes in food allergy and asthma Source: Annual Congress 2005 - Food allergy, atopic dermatitis and asthma Year: 2005
Correlation of biological markers of inflammation in peripheral blood with bronchoprovocative testing with histamine in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 287s Year: 2004
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020